Exscientia (EXAI)
(Real Time Quote from BATS)
$5.61 USD
-0.05 (-0.88%)
Updated Aug 30, 2024 11:58 AM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
Income Statements
Fiscal Year end for Exscientia PLC Sponsored ADR falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 25 | 34 | 38 | 12 | NA |
Cost Of Goods | 34 | 41 | 24 | 18 | NA |
Gross Profit | -9 | -8 | 14 | -6 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 210 | 172 | 90 | 24 | 0 |
Income After Depreciation & Amortization | -219 | -180 | -75 | -30 | 0 |
Non-Operating Income | 19 | 6 | -2 | -1 | NA |
Interest Expense | 1 | 0 | 0 | 0 | NA |
Pretax Income | -202 | -174 | -77 | -31 | NA |
Income Taxes | -20 | -27 | -10 | -3 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | -182 | -147 | -68 | -29 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | -182 | -147 | -68 | -29 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -204 | -170 | -71 | -29 | 0 |
Depreciation & Amortization (Cash Flow) | 15 | 10 | 5 | 1 | NA |
Income After Depreciation & Amortization | -219 | -180 | -75 | -30 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 124.20 | 122.56 | 50.00 | NA | NA |
Diluted EPS Before Non-Recurring Items | -1.50 | -1.17 | -1.33 | NA | NA |
Diluted Net EPS (GAAP) | -1.47 | -1.20 | -1.36 | -0.28 | NA |
Fiscal Year end for Exscientia PLC Sponsored ADR falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 5.58 | 6.71 | 2.97 | 11.24 | 3.76 |
Cost Of Goods | 9.79 | 9.39 | 7.43 | 8.53 | 7.85 |
Gross Profit | -4.22 | -2.68 | -4.46 | 2.71 | -4.09 |
SG&A, R&D, and Dept/Amort Expenses | 45.26 | 31.57 | 53.71 | 49.83 | 54.15 |
Income After SG&A, R&D, and Dept/Amort Expenses | -49.48 | -34.25 | -58.17 | -47.12 | -58.24 |
Non-Operating Income | 4.40 | 4.18 | 4.85 | 4.94 | 5.08 |
Interest Expense | 0.38 | 0.33 | 0.33 | 0.33 | 0.34 |
Pretax Income | -45.47 | -30.40 | -53.66 | -42.51 | -53.49 |
Income Taxes | 0.27 | -3.76 | -2.38 | -3.00 | -8.45 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -45.74 | -26.64 | -51.28 | -39.51 | -45.04 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -45.74 | -26.64 | -51.28 | -39.51 | -45.04 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 126.59 | 125.98 | 125.24 | 124.51 | 123.75 |
Diluted EPS Before Non-Recurring Items | -0.36 | -0.21 | -0.42 | -0.31 | -0.37 |
Diluted Net EPS (GAAP) | -0.37 | -0.22 | -0.41 | -0.32 | -0.36 |